Quantification of HER2 autoantibodies in the amplification phenomenon of HER2 in breast cancer
-
Jens-Jacob L. Lauterlein
,
Eva R.B. Petersen
Abstract
Background: Gene amplification of HER2 (human epidermal growth factor receptor 2) is a well-known phenomenon in various cancers. However, little is known about the mechanism of the gene amplification phenomenon itself. Autoantibodies to cellular receptors have been described in several cancer types. We hypothesised that autoantibodies against HER2 might have a stimulatory capacity and could be the cause of the HER2 gene amplification phenomenon. To investigate this, we developed a test for the detection of autoantibodies against HER2 in serum (S-HER2Ab).
Methods: Blood and tissue samples were collected from 311 women consecutively admitted for surgical treatment of primary breast cancer. Paraffin embedded tissue sections were analysed by immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH). HER2 protein concentrations in tissue were determined in 115 patients. Circulating extracellular domain of HER2 (S-HER2) was measured using the Advia Centaur (Siemens AG, Munich, Germany). Analysis for autoantibodies was developed on an ImmunoCAP 100 (Phadia AB, Uppsala, Sweden) with an automated Fluorescent Enzyme Immuno Assay.
Results: Of 311 women, 55 (17.7%) had HER2Ab and 51 (16.4%) showed amplification of the HER2 gene determined by IHC/FISH. Eleven women had detectable S-HER2Ab as well as HER2 gene amplification, but no statistically significant correlation was found between the two phenomena. A significantly higher level of S-HER2Ab was found both in HER2 gene-amplified and non-amplified breast cancer patients compared to an age-matched healthy control group. No statistically significant difference in presence or concentration of S-HER2Ab was found in HER2 gene-amplified vs. non-amplified breast cancer.
Conclusions: S-HER2Ab can be measured accurately with the ImmunoCAP 100. There is an increased prevalence and concentration of S-HER2Ab in breast cancer patients but no correlation with HER2 gene amplification. We conclude that autoantibodies against HER2 do not seem to be the cause of HER2 gene amplification.
©2011 by Walter de Gruyter Berlin New York
Articles in the same Issue
- Editorials
- Laboratory testing and/or monitoring of the new oral anticoagulants/antithrombotics: for and against?
- Circulating macrocomplexes: old wine in new bottles?
- Review
- Laboratory assessment of new anticoagulants
- Minireviews
- Biomarkers in Alzheimer’s disease
- Analytical variability in sport hematology: its importance in an antidoping setting
- The plodding diagnosis of monogenic autoinflammatory diseases in childhood: from the clinical scenery to laboratory investigation
- Opinion Paper
- Collective opinion paper on findings of the 2010 convocation of experts on laboratory quality
- Genetics and Molecular Diagnostics
- Genetic variability of the fructosamine 3-kinase gene in diabetic patients
- Identification of Bcl-2/IgH fusion sequences using real-time PCR and chip-based microcapillary electrophoresis
- Performance evaluation of a multiplex assay for future use in biomarker discovery efforts to predict body composition
- Pharmacogenetics of tacrolimus after renal transplantation: analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes
- General Clinical Chemistry and Laboratory Medicine
- Quality Indicators in Laboratory Medicine: from theory to practice
- Implementation of computerized add-on testing for hospitalized patients in a large academic medical center
- Human growth hormone (GH) immunoassay: standardization and clinical implications
- Coagulation assays based on the Luminescent Oxygen Channeling Immunoassay technology1)
- Trefoil factor family peptides in human saliva and cyclical cervical mucus. Method evaluation and results on healthy individuals
- Steroid binding properties of the 2nd WHO International Standard for sex hormone-binding globulin
- Thyroxin overdose due to rheumatoid factor interferences in thyroid-stimulating hormone assays
- Cancer Diagnostics
- Quantification of HER2 autoantibodies in the amplification phenomenon of HER2 in breast cancer
- Glycosylation of proteins in healthy and neoplastic human salivary glands – a preliminary study
- Infectious Diseases
- Quantification of cerebrospinal fluid lactic acid in the differential diagnosis between HIV chronic meningitis and opportunistic meningitis
- Cardiovascular Diseases
- Carotid restenosis is associated with plasma ADMA concentrations in carotid endarterectomy patients
- High concentrations of asymmetric dimethylarginine are associated with ST-segment resolution failure after reperfusion for acute myocardial infarction
- An increase in serum uric acid concentrations is associated with an increase in the Framingham risk score in Korean adults
- The effect of a one-year weight reduction program on serum uric acid in overweight/obese children and adolescents
- False positive troponin result caused by a true macrotroponin
- Letters to the Editor
- Patient safety: patient identification wristband errors
- Prevalence of hemolytic specimens referred for arterial blood gas analysis
- “Triage” of lymphoid malignancies in the peripheral blood using the Extended Immunofluorescent Application of the CELL-DYN Sapphire automated hematology analyzer
- Presepsin (sCD14-ST): development and evaluation of one-step ELISA with a new standard that is similar to the form of presepsin in septic patients
Articles in the same Issue
- Editorials
- Laboratory testing and/or monitoring of the new oral anticoagulants/antithrombotics: for and against?
- Circulating macrocomplexes: old wine in new bottles?
- Review
- Laboratory assessment of new anticoagulants
- Minireviews
- Biomarkers in Alzheimer’s disease
- Analytical variability in sport hematology: its importance in an antidoping setting
- The plodding diagnosis of monogenic autoinflammatory diseases in childhood: from the clinical scenery to laboratory investigation
- Opinion Paper
- Collective opinion paper on findings of the 2010 convocation of experts on laboratory quality
- Genetics and Molecular Diagnostics
- Genetic variability of the fructosamine 3-kinase gene in diabetic patients
- Identification of Bcl-2/IgH fusion sequences using real-time PCR and chip-based microcapillary electrophoresis
- Performance evaluation of a multiplex assay for future use in biomarker discovery efforts to predict body composition
- Pharmacogenetics of tacrolimus after renal transplantation: analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes
- General Clinical Chemistry and Laboratory Medicine
- Quality Indicators in Laboratory Medicine: from theory to practice
- Implementation of computerized add-on testing for hospitalized patients in a large academic medical center
- Human growth hormone (GH) immunoassay: standardization and clinical implications
- Coagulation assays based on the Luminescent Oxygen Channeling Immunoassay technology1)
- Trefoil factor family peptides in human saliva and cyclical cervical mucus. Method evaluation and results on healthy individuals
- Steroid binding properties of the 2nd WHO International Standard for sex hormone-binding globulin
- Thyroxin overdose due to rheumatoid factor interferences in thyroid-stimulating hormone assays
- Cancer Diagnostics
- Quantification of HER2 autoantibodies in the amplification phenomenon of HER2 in breast cancer
- Glycosylation of proteins in healthy and neoplastic human salivary glands – a preliminary study
- Infectious Diseases
- Quantification of cerebrospinal fluid lactic acid in the differential diagnosis between HIV chronic meningitis and opportunistic meningitis
- Cardiovascular Diseases
- Carotid restenosis is associated with plasma ADMA concentrations in carotid endarterectomy patients
- High concentrations of asymmetric dimethylarginine are associated with ST-segment resolution failure after reperfusion for acute myocardial infarction
- An increase in serum uric acid concentrations is associated with an increase in the Framingham risk score in Korean adults
- The effect of a one-year weight reduction program on serum uric acid in overweight/obese children and adolescents
- False positive troponin result caused by a true macrotroponin
- Letters to the Editor
- Patient safety: patient identification wristband errors
- Prevalence of hemolytic specimens referred for arterial blood gas analysis
- “Triage” of lymphoid malignancies in the peripheral blood using the Extended Immunofluorescent Application of the CELL-DYN Sapphire automated hematology analyzer
- Presepsin (sCD14-ST): development and evaluation of one-step ELISA with a new standard that is similar to the form of presepsin in septic patients
